Modafinil: Preclinical, Clinical, and Post-Marketing Surveillance—A Review of Abuse Liability Issues

By MYRICK HUGH   MALCOLM ROBERT   TAYLOR BRENT   LaROWE STEVEN  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 16, Iss. 2, 2004-01 ,pp. : 101-109

Informa Healthcare

Access to resources Recommend Favorite

Risperidone in the treatment of affective spectrum disorders and schizophrenia: a large, multicenter post-marketing surveillance study

By Park Jong-Ik   Kim Chang Yoon   Lee Jun Young   Hong Jin Pyo  

Primary Care Psychiatry, Vol. 9, Iss. 4, 2004-12 ,pp. : 131-136

Informa Healthcare

Access to resources Recommend Favorite

Particular aspects of adverse event assessment in post marketing surveillance

By Baier D.  

European Psychiatry, Vol. 13, Iss. 3, 1998-05 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Sertindole: cardiac electrophysiological profile

By Haverkamp W   Eckardt L   Matz J   Frederiksen K  

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 1, 2002-12 ,pp. : 11-20

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Sertindole: safety and tolerability profile

By Kasper S  

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 1, 2002-12 ,pp. : 27-32

Ashgate Publishing Ltd

Access to resources Recommend Favorite